Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Jason Zhang

Jason Zhang

Chief Executive Officer Zipcode Bio

Seminars

Tuesday 21st July 2026

Chair’s Opening Remarks

8:20 am

Wednesday 22nd July 2026

Track B: Pre-Clinical & Clinical Development

Monday 20th July 2026

Minimalist Nanoparticle Designs for RNA Medicines

9:30 am

Leveraging artificial intelligence in mRNA and cirRNA development
Presenting a novel delivery strategy with fresh data insights

Jason Zhang - 6th mRNA-Based Therapeutics Summit Speaker

View all Speakers

View Event Brochure